查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2132382

周邊神經刺激設備市場規模、佔有率和趨勢分析報告：按類型、適應症、作用機制、最終用戶、國家和細分市場預測（2026-2033 年）

Peripheral Nerve Stimulators Market Size, Share & Trends Analysis Report By Type, By Indication, By Mechanism, By End User, By Country And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 300 Pages | 商品交期: 2-10個工作天內

價格

周邊神經刺激設備市場概述

預計到 2025 年，周邊神經刺激設備市場價值將達到 2.993 億美元，到 2026 年將成長至 3.518 億美元，到 2033 年將擴大至 8.981 億美元，在 2026 年至 2033 年期間的複合年成長率為 14.3%。

美國在市場上佔據主導地位，佔銷售額的93.6%。周邊神經病變盛行率的不斷上升是周邊神經刺激設備市場的主要促進因素。

周邊神經刺激 (PNS) 透過向特定周邊神經或其附近區域傳遞電脈衝來調節疼痛訊號，同時避免直接刺激脊髓。該市場涵蓋植入式、經皮和瞬時式周邊神經刺激系統，其應用範圍廣泛，包括周邊神經病變疼痛、術後疼痛、肌肉骨骼疼痛、截肢後疼痛、慢性腰腿痛以及某些類型的頭痛和骨盆腔疼痛。導線設計、刺激程序配置、超音波導引植入、穿戴式組件和瞬時刺激系統等方面的技術進步，拓展了 PNS 的應用範圍，並提高了治療的柔軟性。

由於糖尿病、老化、肥胖、慢性腎臟病、自體免疫疾病、癌症治療以及其他損傷周邊神經的代謝和神經系統疾病的盛行率不斷上升，周邊神經病變的發生率也日益增高。糖尿病性周邊神經病變神經病變仍是此病最常見的類型。雖然化療引起的周邊神經病變已被認為是糖尿病的主要長期併發症，但隨著癌症治療的日益普及，化療引起的周邊神經病變也逐漸成為一個重要的臨床問題。隨著慢性神經病變疼痛、麻木、刺痛和感覺障礙患者人數的持續成長，人們越來越需要超越傳統藥物療法的有效、長期的疼痛管理方案。這種日益加重的疾病負擔正在加速周邊神經刺激設備的應用，該設備提供了一種靶向性強、微創的方法來管理慢性神經病變疼痛，並提高患者的生活品質。

根據 2025 年 4 月發表在 ScienceDirect 上的一項研究，對四個英文資料庫和三個中文資料庫進行全面搜尋，確定了截至 2024 年 6 月 22 日發表的關於糖尿病相關疼痛性周邊神經病變(PDPN) 盛行率的觀察性研究。基於分析的 41 項研究，PDPN 的全球總盛行率為 46.7%。

隨著肌肉骨骼疾病盛行率的上升，越來越多的患者因這些疾病而遭受慢性疼痛和功能障礙的困擾，對周邊神經刺激設備的需求也隨之成長。骨關節炎、慢性下背痛、關節相關疾病和運動傷害等疾病的發生率日益增高，這主要是由於人口老化、肥胖率上升以及運動相關傷害的增加等因素所致。這些肌肉骨骼疾病對患者帶來的負擔日益加重，導致越來越多的人需要長期疼痛管理方案。隨著這些疾病盛行率的持續上升，標靶治療（例如周邊神經刺激）的需求也日益成長，以解決持續性疼痛並改善患者的活動能力。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：周邊神經刺激設備市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 周邊神經刺激設備市場分析工具

第4章：周邊神經刺激設備市場：按類型分類的估算與趨勢分析

  • 按類型分類的周邊神經刺激設備市場波動分析
  • 周邊神經刺激設備市場：按類型分類的規模和趨勢分析，2021-2033年
  • 臨時經皮系統
  • 無線微型嵌入式系統
  • 傳統IPG系統

第5章：周邊神經刺激設備市場：依適應症分類的估算與趨勢分析

  • 依適應症分析周邊神經刺激設備市場波動情況。
  • 周邊神經刺激設備市場：按適應症分類的規模和趨勢分析，2021-2033年
  • 多裂肌功能恢復刺激
  • 周邊神經病變和術後/創傷性疼痛

第6章：周邊神經刺激設備市場：依機制分類的估算與趨勢分析

  • 周邊神經刺激設備神經刺激設備市場：以機制分析市場波動
  • 周邊神經刺激設備市場：周邊神經刺激設備市場規模及趨勢分析（依作用機制分類，2021-2033 年）
  • 外部直接供電
  • 經皮無線電力供應
  • 內建電池供電

第7章：周邊神經刺激設備市場：依最終使用者分類的估算與趨勢分析

  • 周邊神經刺激設備市場終端用戶波動分析
  • 周邊神經刺激設備市場：按最終用戶分類的規模和趨勢分析，2021-2033年
  • 醫院門診部
  • 門診手術中心
  • 門診疼痛治療診所/OBL

第8章：周邊神經刺激設備市場：各國市場估算及趨勢分析

  • 國家/地區概覽
  • 市場規模、預測與趨勢分析，2021-2033年
  • 美國
    • 主要國家的趨勢
    • 競爭格局
    • 法律規範
    • 保險報銷狀態
  • 加拿大
    • 主要國家的趨勢
    • 競爭格局
    • 法律規範
    • 保險報銷狀態
  • 德國
    • 主要國家的趨勢
    • 競爭格局
    • 法律規範
    • 保險報銷狀態
  • 英國
    • 主要國家的趨勢
    • 競爭格局
    • 法律規範
    • 目前保險報銷狀況
  • 義大利
    • 主要國家的趨勢
    • 競爭格局
    • 法律規範
    • 保險報銷狀態
  • 西班牙
    • 主要國家的趨勢
    • 競爭格局
    • 法律規範
    • 保險報銷狀態
  • 丹麥
    • 主要國家的趨勢
    • 競爭格局
    • 法律規範
    • 保險報銷狀態
  • 澳洲
    • 主要國家的趨勢
    • 競爭格局
    • 法律規範
    • 保險報銷狀態
  • 世界其他地區（法國、日本、黎巴嫩、以色列）
    • 主要國家的趨勢
    • 競爭格局
    • 法律規範
    • 保險報銷狀態

第9章 競爭情勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司和競爭對手的分類
    • 創新者
  • 供應商情況
    • 主要銷售代理商和通路夥伴名單
    • Key customers
    • Global Key company market share analysis, 2024
    • Boston Scientific Corporation（Nalu Medical）
    • Medtronic plc（SPR Therapeutics）
    • Curonix LLC（Stimwave Technologies）
    • Neuspera Medical, Inc
    • Bioventus Inc.（StimRouter）
    • NEURIMPULSE srl
    • Nervonik
    • Neuros Medical
    • Mainstay Medical
  • 公司熱圖分析與市場分析
  • 2024年企業市場占有率預測分析
  • 其他主要市場公司
Product Code: GVR-4-68040-753-9

Peripheral Nerve Stimulators Market Summary

The Peripheral Nerve Stimulators Market size was valued at USD 299.3 million in 2025 and is projected to grow from USD 351.8 million in 2026 to USD 898.1 million by 2033, at a CAGR of 14.3% from 2026 to 2033. U.S. dominated the market, accounting for the largest revenue share of 93.6%. The rising prevalence of peripheral neuropathy is a key driver of the peripheral nerve stimulator market.

Peripheral nerve stimulation delivers electrical impulses to or around specific peripheral nerves to modulate pain signals while avoiding direct stimulation of the spinal cord. The market includes implantable, percutaneous, and temporary peripheral nerve stimulation systems, with applications spanning peripheral neuropathic pain, postoperative pain, musculoskeletal pain, post-amputation pain, chronic back and lower-extremity pain, and selected headache and pelvic pain conditions. Technological advancements in lead design, stimulation programming, ultrasound-guided implantation, wearable components, and temporary stimulation systems have expanded the applicability of PNS and improved procedural flexibility.

Peripheral neuropathy is becoming common due to the growing incidence of diabetes, an aging population, obesity, chronic kidney disease, autoimmune disorders, cancer therapies, and other metabolic and neurological conditions that damage peripheral nerves. Diabetic peripheral neuropathy remains the most prevalent form of the disease. It is recognized as a major long-term complication of diabetes, while chemotherapy-induced peripheral neuropathy is also emerging as a significant clinical concern with the expanding use of cancer treatments. As the number of individuals experiencing chronic neuropathic pain, numbness, tingling, and sensory dysfunction continues to rise, there is a growing need for effective long-term pain management solutions beyond conventional pharmacological therapies. This increasing disease burden is accelerating the adoption of peripheral nerve stimulators, which offer a targeted, minimally invasive approach to managing chronic neuropathic pain and improving patients' quality of life.

According to a study published on ScienceDirect in April 2025, a comprehensive search of four English and three Chinese databases identified observational studies on the prevalence of Painful Diabetes-related Peripheral Neuropathy (PDPN) published through June 22, 2024. Based on the 41 studies included in the analysis, the pooled global prevalence of PDPN was 46.7%.

The rising prevalence of musculoskeletal conditions is contributing to the growing demand for peripheral nerve stimulators, as an increasing number of patients experience chronic pain and functional limitations associated with these disorders. Conditions such as osteoarthritis, chronic back pain, joint-related disorders, and sports-related injuries are becoming more common due to factors including population aging, increasing obesity rates, and rising physical activity-related injuries. The growing patient burden associated with these musculoskeletal conditions has increased the number of individuals requiring long-term pain management solutions. As the prevalence of these conditions continues to rise, demand for targeted therapies, such as peripheral nerve stimulation, is increasing to address persistent pain and improve patient mobility.

Peripheral Nerve Stimulators Market Report Segmentation

This report forecasts revenue growth at the global and country levels and provides an analysis of the latest industry trends across sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Peripheral Nerve Stimulators Market report based on type, indication, mechanism, end user, and country:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Temporary Percutaneous Systems
  • Wireless Micro-Implantable Systems
  • Traditional IPG Systems
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Restorative Multifidus Stimulation
  • Peripheral Neuropathic & Post-Surgical/Traumatic Pain
  • Mechanism Outlook (Revenue, USD Million, 2021 - 2033)
  • External Direct Power
  • Transcutaneous Wireless Power
  • Internal Battery Power
  • End User Outlook (Revenue, USD Million, 2021-2033)
  • Hospital Outpatient Departments
  • Ambulatory Surgical Centers
  • Outpatient Interventional Pain Clinics / OBLs
  • Country Outlook (Revenue, USD Million, 2021-2033)
  • U.S.
  • Canada
  • Germany
  • Australia
  • UK
  • Italy
  • Spain
  • Denmark
  • Rest of the World (France, Japan, Lebanon, Israel)

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Indication
    • 1.1.3. Mechanism
    • 1.1.4. End-User
    • 1.1.5. Country scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Peripheral Nerve Stimulators Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of chronic pain disorders
      • 3.2.1.2. Growing preference for minimally invasive therapies
      • 3.2.1.3. Opioid crisis and shift toward non-opioid pain management
      • 3.2.1.4. Expanding applications beyond chronic pain
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of devices and procedures
      • 3.2.2.2. Risk of complications and device-related issues
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Expansion into new indications
      • 3.2.3.2. Adoption in outpatient & home-care settings
      • 3.2.3.3. Rising demand for personalized pain management
      • 3.2.3.4. Integration of Wireless and Wearable Technologies
    • 3.2.4. Market challenge analysis
      • 3.2.4.1. Competition from alternative therapies
      • 3.2.4.2. Patient selection challenges
  • 3.3. Peripheral Nerve Stimulators Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Peripheral Nerve Stimulators Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Peripheral Nerve Stimulators Market Type Movement Analysis
  • 4.3. Peripheral Nerve Stimulators Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 4.4. Temporary Percutaneous Systems
    • 4.4.1. Temporary percutaneous systems market estimates and forecasts for 2021 to 2033 (USD Million)
  • 4.5. Wireless Micro-Implantable Systems
    • 4.5.1. Wireless micro-implantable systems market estimates and forecasts for 2021 to 2033, (USD Million)
  • 4.6. Traditional IPG Systems
    • 4.6.1. Traditional IPG systems market estimates and forecasts for 2021 to 2033, (USD Million)

Chapter 5. Peripheral Nerve Stimulators Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Peripheral Nerve Stimulators Market Indication Movement Analysis
  • 5.3. Peripheral Nerve Stimulators Market Size & Trend Analysis, by Indication, 2021 to 2033 (USD Million)
  • 5.4. Restorative Multifidus Stimulation
    • 5.4.1. Restorative multifidus stimulation market estimates and forecasts for 2021 to 2033, (USD Million)
  • 5.5. Peripheral Neuropathic & Post-Surgical/Traumatic Pain
    • 5.5.1. Peripheral neuropathic & post-surgical/traumatic pain market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 6. Peripheral Nerve Stimulators Market: Mechanism Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Peripheral Nerve Stimulators MarketPeripheral Nerve Stimulators Market Mechanism Movement Analysis
  • 6.3. Peripheral Nerve Stimulators MarketPeripheral Nerve Stimulators Market Size & Trend Analysis, by Mechanism, 2021 to 2033 (USD Million)
  • 6.4. External Direct Power
    • 6.4.1. External direct power market estimates and forecasts for 2021 to 2033, (USD Million)
  • 6.5. Transcutaneous Wireless Power
    • 6.5.1. Transcutaneous wireless power market estimates and forecasts for 2021 to 2033, (USD Million)
  • 6.6. Internal Battery Power
    • 6.6.1. Internal battery power market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 7. Peripheral Nerve Stimulators Market: End-User Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Peripheral Nerve Stimulators Market End-User Movement Analysis
  • 7.3. Peripheral Nerve Stimulators Market Size & Trend Analysis, by End-User, 2021 to 2033 (USD Million)
  • 7.4. Hospital Outpatient Departments
    • 7.4.1. Hospital outpatient departments market estimates and forecasts for 2021 to 2033, (USD Million)
  • 7.5. Ambulatory Surgical Centers
    • 7.5.1. Ambulatory surgical centers market estimates and forecasts for 2021 to 2033 (USD Million)
  • 7.6. Outpatient Interventional Pain Clinics / OBLs
    • 7.6.1. Outpatient interventional pain clinics / OBLs market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 8. Peripheral Nerve Stimulators Market: Country Estimates & Trend Analysis

  • 8.1. Country Dashboard
  • 8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 8.3. U.S.
    • 8.3.1. Key country dynamics
    • 8.3.2. Competitive scenario
    • 8.3.3. Regulatory framework
    • 8.3.4. Reimbursement scenario
    • 8.3.5. U.S. market estimates and forecasts, 2021 - 2033
  • 8.4. Canada
    • 8.4.1. Key country dynamics
    • 8.4.2. Competitive scenario
    • 8.4.3. Regulatory framework
    • 8.4.4. Reimbursement scenario
    • 8.4.5. Canada market estimates and forecasts, 2021 - 2033
  • 8.5. Germany
    • 8.5.1. Key country dynamics
    • 8.5.2. Competitive scenario
    • 8.5.3. Regulatory framework
    • 8.5.4. Reimbursement scenario
    • 8.5.5. Germany market estimates and forecasts, 2021 - 2033
  • 8.6. UK
    • 8.6.1. Key country dynamics
    • 8.6.2. Competitive scenario
    • 8.6.3. Regulatory framework
    • 8.6.4. Reimbursement scenario
    • 8.6.5. UK market estimates and forecasts, 2021 - 2033
  • 8.7. Italy
    • 8.7.1. Key country dynamics
    • 8.7.2. Competitive scenario
    • 8.7.3. Regulatory framework
    • 8.7.4. Reimbursement scenario
    • 8.7.5. Italy market estimates and forecasts, 2021 - 2033
  • 8.8. Spain
    • 8.8.1. Key country dynamics
    • 8.8.2. Competitive scenario
    • 8.8.3. Regulatory framework
    • 8.8.4. Reimbursement scenario
    • 8.8.5. Spain market estimates and forecasts, 2021 - 2033
  • 8.9. Denmark
    • 8.9.1. Key country dynamics
    • 8.9.2. Competitive scenario
    • 8.9.3. Regulatory framework
    • 8.9.4. Reimbursement scenario
    • 8.9.5. Denmark market estimates and forecasts, 2021 - 2033
  • 8.10. Australia
    • 8.10.1. Key country dynamics
    • 8.10.2. Competitive scenario
    • 8.10.3. Regulatory framework
    • 8.10.4. Reimbursement scenario
    • 8.10.5. Australia market estimates and forecasts, 2021 - 2033
  • 8.11. Rest of the World (France, Japan, Lebanon, Israel)
    • 8.11.1. Key country dynamics
    • 8.11.2. Competitive scenario
    • 8.11.3. Regulatory framework
    • 8.11.4. Reimbursement scenario
    • 8.11.5. Rest of the World (France, Japan, Lebanon, Israel) market estimates and forecasts, 2021 - 2033

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
    • 9.2.1. Innovators
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Global Key company market share analysis, 2024
    • 9.3.4. Boston Scientific Corporation (Nalu Medical)
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product Type benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Medtronic plc (SPR Therapeutics)
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product Type benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Curonix LLC (Stimwave Technologies)
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product Type benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Neuspera Medical, Inc
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product Type benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Bioventus Inc. (StimRouter)
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product Type benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. NEURIMPULSE s.r.l.
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product Type benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Nervonik
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product Type benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Neuros Medical
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product Type benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. Mainstay Medical
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product Type benchmarking
      • 9.3.12.4. Strategic initiatives
  • 9.4. Heat Map Analysis/ Company Market Position Analysis
  • 9.5. Estimated Company Market Share Analysis, 2024
  • 9.6. List of Other Key Market Players

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Peripheral Nerve Stimulators Market, by type, USD Million, 2021 - 2033
  • Table 4. Peripheral Nerve Stimulators Market, by indication, USD Million, 2021 - 2033
  • Table 5. Peripheral Nerve Stimulators Market, by mechanism, USD Million, 2021 - 2033
  • Table 6. Peripheral Nerve Stimulators Market, by end user, USD Million, 2021 - 2033
  • Table 7. U.S. peripheral nerve stimulators market, by type, USD Million, 2021 - 2033
  • Table 8. U.S. peripheral nerve stimulators market, by indication, USD Million, 2021 - 2033
  • Table 9. U.S. peripheral nerve stimulators market, by mechanism, USD Million, 2021 - 2033
  • Table 10. U.S. peripheral nerve stimulators market, by end user, USD Million, 2021 - 2033
  • Table 11. Canada peripheral nerve stimulators market, by type, USD Million, 2021 - 2033
  • Table 12. Canada peripheral nerve stimulators market, by indication, USD Million, 2021 - 2033
  • Table 13. Canada peripheral nerve stimulators market, by mechanism, USD Million, 2021 - 2033
  • Table 14. Canada peripheral nerve stimulators market, by end user, USD Million, 2021 - 2033
  • Table 15. Germany peripheral nerve stimulators market, by type, USD Million, 2021 - 2033
  • Table 16. Germany peripheral nerve stimulators market, by indication, USD Million, 2021 - 2033
  • Table 17. Germany peripheral nerve stimulators market, by mechanism, USD Million, 2021 - 2033
  • Table 18. Germany peripheral nerve stimulators market, by end user, USD Million, 2021 - 2033
  • Table 19. Australia peripheral nerve stimulators market, by type, USD Million, 2021 - 2033
  • Table 20. Australia peripheral nerve stimulators market, by indication, USD Million, 2021 - 2033
  • Table 21. Australia peripheral nerve stimulators market, by mechanism, USD Million, 2021 - 2033
  • Table 22. Australia peripheral nerve stimulators market, by end user, USD Million, 2021 - 2033
  • Table 23. UK peripheral nerve stimulators market, by type, USD Million, 2021 - 2033
  • Table 24. UK peripheral nerve stimulators market, by indication, USD Million, 2021 - 2033
  • Table 25. UK peripheral nerve stimulators market, by mechanism, USD Million, 2021 - 2033
  • Table 26. UK peripheral nerve stimulators market, by end user, USD Million, 2021 - 2033
  • Table 27. Italy peripheral nerve stimulators market, by type, USD Million, 2021 - 2033
  • Table 28. Italy peripheral nerve stimulators market, by indication, USD Million, 2021 - 2033
  • Table 29. Italy peripheral nerve stimulators market, by mechanism, USD Million, 2021 - 2033
  • Table 30. Italy peripheral nerve stimulators market, by end user, USD Million, 2021 - 2033
  • Table 31. Spain peripheral nerve stimulators market, by type, USD Million, 2021 - 2033
  • Table 32. Spain peripheral nerve stimulators market, by indication, USD Million, 2021 - 2033
  • Table 33. Spain peripheral nerve stimulators market, by mechanism, USD Million, 2021 - 2033
  • Table 34. Spain peripheral nerve stimulators market, by end user, USD Million, 2021 - 2033
  • Table 35. Denmark peripheral nerve stimulators market, by type, USD Million, 2021 - 2033
  • Table 36. Denmark peripheral nerve stimulators market, by indication, USD Million, 2021 - 2033
  • Table 37. Denmark peripheral nerve stimulators market, by mechanism, USD Million, 2021 - 2033
  • Table 38. Denmark peripheral nerve stimulators market, by end user, USD Million, 2021 - 2033
  • Table 39. Rest of the World (France, Japan, Lebanon, Israel) peripheral nerve stimulators market, by type, USD Million, 2021 - 2033
  • Table 40. Rest of the World (France, Japan, Lebanon, Israel) peripheral nerve stimulators market, by indication, USD Million, 2021 - 2033
  • Table 41. Rest of the World (France, Japan, Lebanon, Israel) peripheral nerve stimulators market, by mechanism, USD Million, 2021 - 2033
  • Table 42. Rest of the World (France, Japan, Lebanon, Israel) peripheral nerve stimulators market, by end user, USD Million, 2021 - 2033

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Peripheral Nerve Stimulators Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Country Marketplace: Key Takeaways
  • Fig. 14 Peripheral Nerve Stimulators Market, by Type, 2021 - 2033 (USD Million)
  • Fig. 15 Peripheral Nerve Stimulators Market, for Temporary Percutaneous Systems, 2021 - 2033 (USD Million)
  • Fig. 16 Peripheral Nerve Stimulators Market, for Wireless Micro-Implantable Systems, 2021 - 2033 (USD Million)
  • Fig. 17 Peripheral Nerve Stimulators Market, for Traditional IPG Systems, 2021 - 2033 (USD Million)
  • Fig. 18 Peripheral Nerve Stimulators Market, by Indication, 2021 - 2033 (USD Million)
  • Fig. 19 Peripheral Nerve Stimulators Market, for Restorative Multifidus Stimulation, 2021 - 2033 (USD Million)
  • Fig. 20 Peripheral Nerve Stimulators Market, for Peripheral Neuropathic & Post-Surgical/Traumatic Pain, 2021 - 2033 (USD Million)
  • Fig. 21 Peripheral Nerve Stimulators Market, by Mechanism, 2021 - 2033 (USD Million)
  • Fig. 22 Peripheral Nerve Stimulators Market, for External Direct Power, 2021 - 2033 (USD Million)
  • Fig. 23 Peripheral Nerve Stimulators Market, for Transcutaneous Wireless Power, 2021 - 2033 (USD Million)
  • Fig. 24 Peripheral Nerve Stimulators Market, for Internal Battery Power, 2021 - 2033 (USD Million)
  • Fig. 25 Peripheral Nerve Stimulators Market, by End User, 2021 - 2033 (USD Million)
  • Fig. 26 Peripheral Nerve Stimulators Market, for Hospital Outpatient Departments, 2021 - 2033 (USD Million)
  • Fig. 27 Peripheral Nerve Stimulators Market, for Ambulatory Surgical Centers, 2021 - 2033 (USD Million)
  • Fig. 28 Peripheral Nerve Stimulators Market, for Outpatient Interventional Pain Clinics / OBLs, 2021 - 2033 (USD Million)
  • Fig. 29 Country Outlook, 2024 & 2033
  • Fig. 30 U.S. Peripheral Nerve Stimulators Market, 2021 - 2033 (USD Million)
  • Fig. 31 Canada Peripheral Nerve Stimulators Market, 2021 - 2033 (USD Million)
  • Fig. 32 Germany Peripheral Nerve Stimulators Market, 2021 - 2033 (USD Million)
  • Fig. 33 Australia Peripheral Nerve Stimulators Market, 2021 - 2033 (USD Million)
  • Fig. 34 UK Peripheral Nerve Stimulators Market, 2021 - 2033 (USD Million)
  • Fig. 35 Italy Peripheral Nerve Stimulators Market, 2021 - 2033 (USD Million)
  • Fig. 36 Spain Peripheral Nerve Stimulators Market, 2021 - 2033 (USD Million)
  • Fig. 37 Denmark Peripheral Nerve Stimulators Market, 2021 - 2033 (USD Million)
  • Fig. 38 Rest of the World (France, Japan, Lebanon, Israel) Peripheral Nerve Stimulators Market, 2021 - 2033 (USD Million)